|
|
Article: Caliper Life Sciences Expands LabChip[R] GX Product Capabilities, Broadens Application Focus, and Achieves Adoption Milestones.
- Article from:
- Vaccine Weekly
- Article date:
- November 18, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Caliper Life Sciences, Inc. (NASDAQ:CALP), a leading provider of life sciences tools, announced the availability of two new products that expand the LabChip GX product line: a GLP/GMP-compliant version of the operating software for the LabChip GX instrument that is amenable to manufacturing QC environments and a new protein assay with higher, silver stain levels of sensitivity. The LabChip GX platform has been broadly adopted by biopharmaceutical companies and academic institutions for protein therapeutics, vaccines, and nucleic acid applications (see also Virology).
"Our LabChip GX platform provides unique speed, throughput, cost, and data quality advantages for ...
Related newspaper, magazine, and journal articles:
|
|
Article: Caliper Life Sciences Reports Second Quarter 2008 ...
PR Newswire;
August 6, 2008 ;
700+ words
... ... PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. today reported second quarter ... sequential quarter basis. -- The new LabChip GX instrument series, the next generation ... was launched after quarter end. The LabChip GX instruments are targeted at the expanding ...
|
|